Clinical Trial Update: A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Krystal Biotech's KB707 is being studied in a Phase 1/2 trial for locally advanced or metastatic solid tumors, including cutaneous melanoma, with recruitment on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Melanoma

Drugs mentioned

• KB707

Snippet

Sponsor: Krystal Biotech, Inc. | Conditions: Cancer, Melanoma Stage III | Phase 1, Phase 2 | Status: RECRUITING